Skip to content

Merit Medical Systems MMSI Cash Provided by (Used in) Financing Activity, Including Discontinued Operation

Cash Provided by (Used in) Financing Activity, Including Discontinued Operation at other companies

TFX
TeleflexTFX
-$44.99M+24.4%
Haemonetics logo
HaemoneticsHAE
-$101.5M
UFP Technologies logo
UFP TechnologiesUFPT
-$1.62M+84.9%
LivaNova logo
LivaNovaLIVN
-$94.25M-2,032%
Medtronic logo
MedtronicMDT
Solventum logo
SolventumSOLV

Other financials

Income statement

See full
Revenue$381.9M+7.5%
Gross profit$184.8M+7.4%
Operating income$44.2M+7.6%
Net income$41.0M+36.0%
EPS (diluted)$0.68+38.8%

Balance sheet

See full
Cash & equivalents$488.1M+23.4%
Total debt$821.6M+0.5%
Total equity$1.6B+13.9%
Total assets$2.7B+10.2%

Cash flow

See full
Operating cash flow$40.7M+0.3%
CapEx$16.0M-24.0%
Free cash flow$24.7M+26.5%

Valuation

See full
Market cap$4.01B-34.1%

Profitability

See full
Gross margin48.7%+0.9pp
Operating margin12.2%+0.6pp
Net margin9%+0.2pp
FCF margin14.3%+1.3pp

Returns & leverage

See full
Return on equity9.1%0.0pp
Debt / equity0.5×-0.1×
Current ratio5.1×+0.2×

Where this comes from

Reported directly by Merit Medical Systems in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Merit Medical Systems’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Merit Medical Systems's cash provided by (used in) financing activity, including discontinued operation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Merit Medical Systems's cash provided by (used in) financing activity, including discontinued operation?
Merit Medical Systems (MMSI) reported cash provided by (used in) financing activity, including discontinued operation of -$6.29M in Q1 2026.
How has Merit Medical Systems's cash provided by (used in) financing activity, including discontinued operation changed year-over-year?
Merit Medical Systems's cash provided by (used in) financing activity, including discontinued operation decreased by 190.4% year-over-year, from $6.96M to -$6.29M.
What is the long-term trend for Merit Medical Systems's cash provided by (used in) financing activity, including discontinued operation?
Over 3 years (2021 to 2025), Merit Medical Systems's cash provided by (used in) financing activity, including discontinued operation has grown at a -45.0% compound annual growth rate (CAGR), from -$98.44M to $16.36M.
What does cash provided by (used in) financing activity, including discontinued operation mean?
This metric measures the net cash flow between the company and its capital providers, including proceeds from debt or equity issuance and payments for dividends or share repurchases. It highlights how the company finances its operations and returns value to shareholders.